Business Context and Reporting Period
Company: Bristol-Myers Squibb Company (BMY)
Filing Type: Form 8-K (Current Report)
Date of Report: April 29, 2022
Reporting Period: First Quarter of 2022
This filing serves as a notification that the Company issued an Earnings Press Release and supplemental information regarding its financial results for the first quarter of 2022. The filing incorporates by reference the press release, supplemental data, and a presentation deck used during the earnings conference call.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the referenced Earnings Press Release (Exhibit 99.1) and Supplemental Information (Exhibit 99.2), which are not included in the body of this 8-K text.
Material Changes
The filing does not explicitly list material changes versus the prior comparable period within the text provided. It directs investors to the incorporated exhibits for the full analysis of operational and financial changes for the first quarter of 2022.
Guidance, Outlook, and Risks
- Management Commentary: The Company posted a presentation (Exhibit 99.3) on its website containing financial and operating initiatives discussed during the April 29, 2022, conference call.
- Non-GAAP Measures: The presentation includes non-GAAP financial information. Reconciliations to GAAP measures are available in the Supplemental Information (Exhibit 99.2).
- Regulatory Note: Information in Item 7.01 (Regulation FD Disclosure) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities thereof, except as specifically incorporated by reference in future filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for specific Q1 2022 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 (Supplemental Information) for reconciliations between non-GAAP and GAAP financial measures.
- Access Exhibit 99.3 (Presentation Materials) for management's outlook and discussion of operating initiatives.
- Verify the availability of the presentation on the Company's website, as the Company reserves the right to discontinue access at any time.